Market Brief

The articles are produced in Chinese only.


研究部 (Research Team)


香港ETF介紹(四)——華夏滬深300指數基金 (3188.HK)

Friday, November 01, 2019 Views3534

基本資料:華夏滬深300指數基金是一隻指數追蹤基金,其旨在於扣除費用前盡實際可能緊貼滬深300指數之表現。華夏滬深300指數ETF主要投資於該中國境內證券市場滬深300指數之成份股。 基金的買賣單位為每手200股。截至2019年10月30日,基金持股比重最大的十間公司(按所佔比重大小排序)為中國平安、貴州茅臺 、招商銀行 、格力電器 、恒瑞醫藥 、興業銀行 、美的集團 、五糧 液 、中信證券 、伊利股份 。

技術分析:聯儲局公開市場委員會(FOMC)結束一連兩日議息會議,於本港時間周四凌晨二時宣布議息結果,把聯邦基金目標利率下調0.25厘,減至1.5%至1.75%區間。 這是美聯儲今年第三次降息,符合市場預期。美元連續三次降息為人民幣寬鬆打開空間,對A股是有利的。從中長期看,中期A股會企穩一步步向上

从技術角度來看,3188.HK在 100日線(43.50元)有支撐。


This report is produced and is being distributed in Hong Kong by Phillip Securities Group with the Securities and Futures Commission (“SFC”) licence under Phillip Securities (HK) LTD and/ or Phillip Commodities (HK) LTD (“Phillip”). Information contained herein is based on sources that Phillip believed to be accurate. Phillip does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The information is for informative purposes only and is not intended to or create/induce the creation of any binding legal relations. The information provided do not constitute investment advice, solicitation, purchase or sell any investment product(s). Investments are subject to investment risks including possible loss of the principal amount invested. You should refer to your Financial Advisor for investment advice based on your investment experience, financial situation, any of your particular needs and risk preference. For details of different product's risks, please visit the Risk Disclosures Statement on Phillip (or employees) may have positions/ interests in relevant investment products. Phillip (or one of its affiliates) may from time to time provide services for, or solicit services or other business from, any company mentioned in this report. The above information is owned by Phillip and protected by copyright and intellectual property Laws. It may not be reproduced, distributed or published for any purpose without prior written consent from Phillip.
Top of Page
Contact Us
Please contact your account executive or call us now.
Research Department
Tel : (852) 2277 6846
Fax : (852) 2277 6565
Email :

Enquiry & Support
The Complaint Procedures
Louis Talk
Investor Notes
Free Subscribe
Contact Us